Location: Wales, UK
Application deadline: 10th April 2012
Applications are invited for a PhD studentship in areas relating to medicines use, pharmaceutical economics or policy at the Centre for Health Economics and Medicines Evaluation, Bangor University. This full-time, 3-year studentship provides full support for tuition fees (for UK/EU nationals), all associated research costs and a tax-free stipend. Studentships are currently £13,590 in the first year, with annual increments thereafter.
This PhD will relate to one of the Centre’s medicines-related research activities:
- Pharmaceutical economics and policy research: including the economic assessment of all new medicines in Wales; and policies related with the appraisal of new medicines, including: orphan drug status, biosimilars, evergreened products, pharmaceutical innovation, prescription charges, generic substitution and value-based pricing;
- Variability in response to medicines: including the assessment of the impact of non-adherence on treatment effectiveness and cost-effectiveness; and the economics of pharmacogenetic tests;
- Methodological research related to trial-based economic assessments: including measures of health outcome, methods for resource use data measurement, and cost-effectiveness estimation based on pharmacokinetic-pharmacodynamic models;
- Applied research in trial-based economic evaluations: including trials in children, and adults with depression, cancer, epilepsy
How to Apply
To apply for this studentship please submit an application via the University’s on-line admissions facility. Please ensure this includes an outline of no more than two pages of the proposed research.
Applicants should hold a first class or upper-second-class degree in economics, pharmacy or a relevant quantitative, clinical or biomedical discipline. A Masters qualification in a relevant discipline (e.g. health economics, statistics or operational research) would be an advantage.
The award is available to UK and other EU nationals only. Non-UK EU nationals must be resident in the UK for three years prior to the start of the studentship, otherwise they will be eligible for a fees-only award. The studentship is available from October 2012.
For further information please contact: Professor Dyfrig Hughes firstname.lastname@example.org
The closing date for applications is 10th April 2012.
Closing date: Friday 13th April 2012
Glasgow Caledonian University is building on its RAE 2008 success to develop future capacity in its areas of strength. We are seeking PhD applications from highly qualified individuals in areas which fit with our own research excellence.
Two studentships are offered in the area of health economics. For further details and how to apply please visit the GCU website http://www.gcu.ac.uk/research/phdstudentships/.
Location: Berkeley, California, USA
Venue: Claremont Resort Hotel
Dates: April 17-21, 2012
The executive program on innovative solutions in health policy, technology and management: University of California, Berkeley, the King’s Fund, London and UPF’s CRES, Barcelona
GHLF energizes health care executives/leaders through cutting edge, globally-sourced solutions and debates with experts on health care policy, technology and management issues. The Global Health Leadership Forum is currently accepting applications and nominations for its 2012 cycle. Participants have lauded the wisdom in health economics which informs most of the topics. The network of past alumni includes 200 health care leaders from 53 countries over 8 years. Application is on-line through the website.
Note that we are offering a total of $2000 discount off of the Berkeley and London sessions if registration is received and paid for by February 15, 2012. Also, due to enthusiastic feedback, we are again offering an optional Kaiser Permanente field trip directly after the GHLF—April 22-25, 2012. Save time and travel costs; discount from GHLF and KP for attending both.
Although most participants have chosen to go to both sessions and receive an earned certificate, applicants may choose to go to one session only.
Focus includes recent innovations in insurance design and payment methods, delivery, care integration, public-private investment partnerships, technology solutions for tele-health and consumer engagement, lessons in health systems strengthening from Asia and the Americas, and leadership styles and strategies. The session includes field trips to two innovative healthcare sites and an option to visit Kaiser Permanente.
See website for full agenda. Among the April 2012 GHLF Speakers:
Sir Richard Feachem, Founding Executive Director of Global Fund, and UCSF Global Health Sciences
Neelam Sekhri Feachem, President, Healthcare Redesign and SVP, Napo Pharma
Chris Ham CEO, UK King’s Fund
Rahul Reddy, CEO innovations, Apollo hospitals, India
Jason Cheah, CEO Agency for Integrated Care, Singapore
Dov Chernichovsky, expert in comparative health systems, Israel
Mark Smith CEO, California Healthcare Foundation
Steve Shortell, Dean, UC Berkeley School of Public Health Richard Scheffler, Distinguished Professor of Health Economics and Public Policy Jenny Chatman, Organizational effectiveness expert and PhD Director, Haas Business School Chuck Slaughter, CEO, Livinggoods Teh Wei Hu, Professors of Health Economics, China and Taiwan expert, UC Berkeley
Location: The Kings Fund, London England
Dates: September 16-21, 2012
Focus includes successes in European health systems redesign, delivery system performance, how to prioritize benefits and services (including UK’s NICE experience and the US practice of comparative effectiveness), pharma: innovation, access and cost-containment, governance and regulation, chronic disease management, and field trips to innovative ambulatory and hospital organizations.
Systematic Review and Meta-analysis of Direct, Indirect and Mixed Treatment Evidence: University of Gl
Location: Glasgow, Scotland
Dates: 18th-20th April 2012
The Health Economics and Health Technology Assessment (HEHTA) Team at the University of Glasgow are pleased to announce a three day course on conducting systematic reviews and meta-analyses.
Through a series of lectures and hands-on workshops (using Stata and WinBUGS), this course will cover the principles and practice of conducting a systematic review and meta-analysis of a variety of measures of treatment effects. In addition, participants will learn the important aspects of network meta-analysis, going beyond traditional pairwise techniques when comparing multiple treatment options.
The course is suitable for clinicians, health service researchers and other healthcare professionals who are involved in systematic reviews and meta-analyses as a piece of independent work or an integral part of a health technology assessment.
Participants should have knowledge of basic medical statistics. A basic appreciation of research design would be helpful, as would basic knowledge of Stata and WinBUGS. A one day introduction to Stata is available on 17 April for those less familiar with the software.
More information can be found on the course webpage see http://www.gla.ac.uk/researchinstitues/healthwellbeing/hehta/
Further details and booking information are available from the HEHTA administrator: email@example.com
Location: Lausanne, Switzerland
Dates: April 23 to 27, 2012
Registration: Online until April 6, 2012
Course hompage: http://www.hec.unil.ch/iems/formation/phd
Prof. Alistair McGuire (London School of Economics)
Prof. Mireia Jofre-Bonet (City University of London)
Welfare economics concerns the means by which the desirability of different policy options can be judged, and provides the theoretical foundations for the economic evaluation techniques currently widely used in policy making.
The aim of this module is to revise the subject of welfare economics and extend it to incorporate recent advances in this topic.
This course will provide an overview of the concepts that are essential for the understanding of the theoretical underpinnings of welfare economics. It will also show how the different approaches are applied empirically.
By the end of the course, you will be familiar with what social welfare functions are and how welfare changes and the distributional implications associated to health care interventions are measured - including when there are no markets and/or prices for the goods and/or services involved.
You will be able to apply and understand evaluation techniques such as cost-effectiveness and cost-utility analysis, cost-benefit analysis and establish when recommendations emerging from those analyses are associated with gains in the social welfare function.
You will be acquainted with the different outcome measures as used in the health sector (Quality Adjusted Life Years, Disability Life Years, Health-Years Equivalents); the properties of the contingent valuation approach; the conjoint/stated preference analysis approach; and estimation approaches for the marginal social cost of funds.
Finally, expected utility theory, decision theory, and optimal taxation will be examined in the light of cost-effectiveness analysis and welfare economics.
Location: Mannheim, Germany
The mission of the Master of Science in Health Economics (MScHE) program is to provide first-class training in the theoretical foundations and practical applications of health economic methods for decision-making and policy development in health and health care, within the context of the ethical principles of society.
The foundation for specialization in health economics is provided through coursework in the core areas of health economics, specifically microeconomics, econometrics, and economic evaluation of health and health care programs.
The learning outcomes for students in the MScHE program include the development of a thorough knowledge of the theory and methods used by professional health economists and active researchers in the field and their important contemporary contributions in international scholarly journals.
The program is open to medical doctors and other professionals with a health-related first academic degree equivalent to 240 ECTS (usually a Bachelor’s degree after at least four years of full-time study).
High motivation, self-reliance and a collaborative spirit are qualities that participants should hold and display. Prospective participants are expected to clearly describe their academic and personal goals and study and research interests in undertaking the program in a “Personal Statement” of two pages.
Mannheim Institute of Public Health, Social and Preventive Medicine
phone: +49 621 383 9910
fax: +49 621 383 9920